Antinuclear antibodies: two-step detection strategy

References

• Antico A, Platzgummer S, Bassetti D, et al. (2010). Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test. Lupus, 19, 906–12
   Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV, et al. (2003). Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med, 349, 1526–33
   PubMed Web of Science ®Google Scholar
• Arends S, Lebbink HR, Spoorenberg A, et al. (2010). The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis. Clin Exp Rheumatol, 28, 661–8
   PubMed Web of Science ®Google Scholar
• Bradwell AR, Stokes RP, Johnson GD. (1995). Atlas of HEp-2 Patterns. ed. The Binding Site LTD, Birmingham, UK, p. 118
   Google Scholar
• Callado MRM, Vieira RMRA, Araújo VMA, et al. (2007). Prevalência dos anticorpos antinucleares (ANA) no Hospital Geral de Fortaleza no período de jan/2002 a dez/2006. Jornal da Liga dos Reumatologistas do Norte-Nordeste (LIRNNE), 3, 118–22
   Google Scholar
• Caramaschi P, Ruzzenente O, Pieropan S, et al. (2007). Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results. Rheumatol Int, 27, 649–54
   Google Scholar
• Carp HJ, Selmi C, Shoenfeld Y. (2012). The autoimmune bases of infertility and pregnancy loss. J Autoimmun, 38, J266–74
   PubMed Web of Science ®Google Scholar
• Carvalho FPL, Andrade LEC, Cruvinel WM, et al. (2009). III Consenso Brasileiro para Pesquisa de Autoanticorpos em Células HEp-2: perspectiva histórica, controle de qualidade e associações clínicas. J Bras Patol Med Lab, 45, 185–99
   Google Scholar
• Cline AM, Kutteh WH. (2009). Is there a role of autoimmunity in implantation failure after in-vitro fertilization? Curr Opin Obstet Gynecol, 21, 291–5
   Google Scholar
• Cornec D, Avouac J, Youinou P, Saraux A. (2009). Critical analysis of rituximab-induced serological changes in connective tissue diseases. Autoimmun Rev, 8, 515–9
   PubMed Web of Science ®Google Scholar
• Dellavance A, Gabriel Junior A, Cintra AFU, et al. (2003). II Consenso Brasileiro de Fator Antinuclear em Células HEp-2. Rev Bras Reumatol, 43, 129–40
   Google Scholar
• El-Chennawi FA, Mosaad YM, Habib HM, El-Degheidi T. (2009). Comparative study of antinuclear antibody detection by indirect immunofluorescence and enzyme immunoassay in lupus patients. Immunol Invest, 38, 839–50
   PubMed Web of Science ®Google Scholar
• Ferreira AW, Ávila SLM. (2001). Sorologia: Importância e parâmetros. In: Ferreira AW, Ávila SLM. Diagnóstico Laboratorial das principais doenças infecciosas e auto-imunes. 2 ed. Guanabara Koogan, Rio de Janeiro, pp. 1–8
   Google Scholar
• Ghillani P, Rouquette AM, Desgruelles C, et al. (2007). Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases. Ann NY Acad Sci, 1109, 407–13
   PubMedGoogle Scholar
• Hoxha A, Ruffatti A, Grypiotis P, et al. (2006). Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatment with infliximab. Reumatismo, 58, 121–6
   Google Scholar
• Ippolito A, Wallace DJ, Gladman D, et al. (2011). Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus, 20, 250–5
   Google Scholar
• Kavanaugh A, Tomar R, Reveille J, et al. (2000). Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med, 124, 71–81
   PubMed Web of Science ®Google Scholar
• Lima MRM, Domínguez JIS, Solis RG, Botello MÊS. (2010). Comparación entre quimioluminiscencia e inmunofluorescencia indirecta en la determinación de anticuerpos antinucleares. Rev Mex Patol Clin, 57, 100–4
   Google Scholar
• Meroni PL, Schur PH. (2010). ANA screening: an old test with new recommendations. Ann Rheum Dis, 69, 1420–2
   PubMed Web of Science ®Google Scholar
• Novak S, Anić B, Anić F, et al. (2011). Clinical significance of autoantibodies induced by infliximab treatment: two-year follow-up after infliximab discontinuation. Acta Dermatovenerol Croat, 19, 156–60
   Google Scholar
• Puertas-Abreu E, Polanco ER, Azocar M, et al. (2012). Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α. Int Arch Med, 5, 7
   Google Scholar
• Tan EM, Feltkamp TE, Smolen JS, et al. (1997). Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum, 40, 1601–11
   PubMed Web of Science ®Google Scholar
• Ying Y, Zhong YP, Zhou CQ, et al. (2012). Antinuclear antibodies predicts a poor IVF-ET outcome: impaired egg and embryo development and reduced pregnancy rate. Immunol Invest, 41, 458–68
   PubMed Web of Science ®Google Scholar
• Yukawa N, Fujii T, Kondo-Ishikawa S, et al. (2011). Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study. Arthritis Res Ther, 13, R213
   PubMed Web of Science ®Google Scholar